Roche will get the rights to manufacture and commercialise a 'promising' new treatment for inflammatory bowel disease under this new deal.
Read more: Roche to acquire Telavant Holdings for $7.1bn
https://bit.ly/45Hv2Sb
Read more: Roche to acquire Telavant Holdings for $7.1bn
https://bit.ly/45Hv2Sb